Published in Infect Genet Evol on March 28, 2012
Leishmania aethiopica field isolates bearing an endosymbiontic dsRNA virus induce pro-inflammatory cytokine response. PLoS Negl Trop Dis (2014) 0.95
Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil. Mem Inst Oswaldo Cruz (2014) 0.90
Mapping the genes for susceptibility and response to Leishmania tropica in mouse. PLoS Negl Trop Dis (2013) 0.78
Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil. Ann Hum Genet (2017) 0.77
MtDNA CytB Structure of Rhombomys opimus (Rodentia: Gerbellidae), the Main Reservoir of Cutaneous Leishmaniasis in the Borderline of Iran-Turkmenistan. J Arthropod Borne Dis (2013) 0.76
Fine mapping under linkage peaks for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil. Infect Genet Evol (2016) 0.76
Morinda citrifolia Linn. Reduces Parasite Load and Modulates Cytokines and Extracellular Matrix Proteins in C57BL/6 Mice Infected with Leishmania (Leishmania) amazonensis. PLoS Negl Trop Dis (2016) 0.76
Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1. Infect Genet Evol (2015) 0.75
Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection. Infect Genet Evol (2017) 0.75
Therapeutic effect of acupuncture in BALB/c model of cutaneous leishmaniasis. Adv Biomed Res (2015) 0.75
PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet (1998) 23.25
Growth factors and cytokines in wound healing. Wound Repair Regen (2009) 7.14
Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet (1999) 4.07
Case/pseudocontrol analysis in genetic association studies: A unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol (2004) 3.39
A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med (2007) 2.95
Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun (2002) 2.90
Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg (1986) 2.57
TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta (2009) 2.44
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med (1995) 2.30
A note on power approximations for the transmission/disequilibrium test. Am J Hum Genet (1999) 2.25
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum (2006) 2.02
TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) (2011) 1.90
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet (1999) 1.57
Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem (2006) 1.49
Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet (2006) 1.47
Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J Immunol (2008) 1.46
IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis (2006) 1.38
The role of host genetics in leishmaniasis. Trends Parasitol (2009) 1.34
CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing. Histol Histopathol (2008) 1.23
Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol (2009) 1.21
Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol Res (1993) 1.20
Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J Biol Chem (2010) 1.12
Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period. Am J Trop Med Hyg (2012) 1.11
Future treatments in systemic sclerosis. J Dermatol (2010) 1.06
The wound repair response controls outcome to cutaneous leishmaniasis. Proc Natl Acad Sci U S A (2005) 1.06
Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J (2009) 1.05
Geographic clustering of leishmaniasis in northeastern Brazil. Emerg Infect Dis (2009) 1.02
Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun (2010) 1.00
Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis Rheum (2001) 0.99
CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. BMC Med Genet (2010) 0.99
Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J Surg Res (2009) 0.98
The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infect Genet Evol (2010) 0.95
Genes and environment in susceptibility to visceral leishmaniasis. C R Biol (2006) 0.94
Release of TNF-α from macrophages is mediated by small GTPase Rab37. Eur J Immunol (2011) 0.93
FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil. Genes Immun (2011) 0.91
Slc11a1 (Nramp1) alleles interact with acute inflammation loci to modulate wound-healing traits in mice. Mamm Genome (2007) 0.88
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. J Pathol (2011) 0.87
Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor. J Invest Dermatol (2006) 0.86
Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta (2011) 0.85
Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein. World J Gastroenterol (2011) 0.82
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
The genome of the kinetoplastid parasite, Leishmania major. Science (2005) 8.64
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56
Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet (2009) 4.61
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet (2010) 4.42
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet (2002) 3.75
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun (2002) 2.90
HLA and infectious diseases. Clin Microbiol Rev (2009) 2.35
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun (2005) 2.29
Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis (2007) 2.08
Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis (2002) 2.06
Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett (2005) 1.94
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis (2007) 1.63
Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis (2002) 1.60
Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect Dis (2006) 1.56
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infect Dis (2002) 1.51
Mucosal leishmaniasis: epidemiological and clinical aspects. Braz J Otorhinolaryngol (2008) 1.49
Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. J Clin Microbiol (2011) 1.48
IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol (2005) 1.48
Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis (2001) 1.44
Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis (2002) 1.42
Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. PLoS Negl Trop Dis (2010) 1.40
Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis (2004) 1.39
IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis (2006) 1.38
P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol (2010) 1.33
Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One (2008) 1.32
Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response. Trans R Soc Trop Med Hyg (2011) 1.27
Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol (2003) 1.24
Clinical manifestations associated with HTLV type I infection: a cross-sectional study. AIDS Res Hum Retroviruses (2007) 1.20
Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J Infect Dis (2004) 1.17
Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10. Infect Immun (2008) 1.16
Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun (2004) 1.15
Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet (2013) 1.15
IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog (2013) 1.15
Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil. Am J Trop Med Hyg (2009) 1.14
Protective and pathologic immune responses in human tegumentary leishmaniasis. Front Immunol (2012) 1.13
Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals. Int Braz J Urol (2007) 1.12
Interleukin 17 production among patients with American cutaneous leishmaniasis. J Infect Dis (2009) 1.12
Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function. Infect Immun (2007) 1.11
Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis. BMC Infect Dis (2007) 1.11
Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period. Am J Trop Med Hyg (2012) 1.11
Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis. J Infect Dis (2006) 1.11
Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan. J Infect Dis (2007) 1.09
Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. J Infect Dis (2014) 1.09
Evidence of in situ cytotoxicity in American cutaneous leishmaniasis. Eur J Dermatol (2002) 1.09
Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease. Am J Trop Med Hyg (2010) 1.07
Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Genet (2005) 1.06
Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan. PLoS Genet (2007) 1.06
Urinary and sexual manifestations of patients infected by HTLV-I. Clinics (Sao Paulo) (2007) 1.05
Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis. Curr Opin Infect Dis (2008) 1.05
Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis (2012) 1.04
Geographic clustering of leishmaniasis in northeastern Brazil. Emerg Infect Dis (2009) 1.02
From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection. Vaccine (2005) 1.02
Clinical manifestations in individuals with recent diagnosis of HTLV type I infection. J Clin Virol (2011) 1.02
Genome-wide association study to identify the genetic determinants of otitis media susceptibility in childhood. PLoS One (2012) 1.02
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia). PLoS Negl Trop Dis (2011) 1.00
HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite. Blood (2007) 0.99
CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. BMC Med Genet (2010) 0.99
Unraveling the genetics of otitis media: from mouse to human and back again. Mamm Genome (2010) 0.98
Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity. J Leukoc Biol (2004) 0.98
Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect Dis (2010) 0.97
Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection. Infect Immun (2005) 0.97
IFN-γ production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection. PLoS Negl Trop Dis (2012) 0.97
Characterization of the immune response to Leishmania infantum recombinant antigens. Microbes Infect (2003) 0.97
The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study. BMC Infect Dis (2007) 0.96
Genetic admixture in Brazilians exposed to infection with Leishmania chagasi. Ann Hum Genet (2009) 0.96
Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder. Urology (2010) 0.95
The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infect Genet Evol (2010) 0.95